Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter

RegulatoryArgatroban InjectionNegative

AI Analysis

Summary

Par Health issued a voluntary nationwide recall of 22 lots of Argatroban Injection 250 mg/2.5 mL due to the presence of particulate matter contamination at the hospital/user level.

Outcome Details

Voluntary nationwide recall due to presence of particulate matter (cellulose, polystyrene, polyethylene)

Importance:4/10

Sentiment:

-0.80

recallproduct_safetyquality_issueparticulate_matter

Related Companies

$HIT

Read the original article

Published by PR Newswire Biotech on October 13, 2026 8:30 PM

Read Original